IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen ExpressionMarkus Chmielewski, Hinrich Abken|Cancer Research|2011Cited by 541
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz, Markus Chmielewski|Cell Reports Medicine|2024Cited by 13